Grant agreement number: (no. JPIAMR2022-020)
Aim of the project: Project aims to assess the efficacy of lyophilized fecal microbiota transplantation product for primary Clostridioides difficile infection in comparison to standard antibiotic therapy in a randomizes controlled multicenter trial.
Source of funding: EU Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)